Medical Technology - Southern Asia

  • Southern Asia
  • The projected revenue in the Medical Technology market market in Southern Asia is estimated to reach US$10.57bn in 2024.
  • Among the markets, Medical Devices is expected to be the largest, with a projected market volume of US$8.43bn in 2024.
  • The market is anticipated to experience an annual growth rate (CAGR 2024-2028) of 7.68%, leading to a market volume of US$14.21bn by 2028.
  • In comparison to other countries globally, the United States is projected to generate the highest revenue, amounting to US$215.80bn in 2024.
  • In Southern Asia, the medical technology market is rapidly expanding, with India leading the way in innovative solutions and affordable healthcare devices.

Key regions: United States, Germany, China, Japan, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Medical Technology market in Southern Asia is experiencing significant growth and development due to several key factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the expansion of the Medical Technology sector in this region. Customer preferences in Southern Asia are driving the demand for advanced medical technologies. The population in this region is increasingly aware of the benefits of modern healthcare solutions and is seeking access to state-of-the-art medical devices and equipment. Patients are looking for accurate and reliable diagnostic tools, minimally invasive surgical procedures, and personalized treatment options. As a result, medical technology companies are focusing on developing innovative products that cater to these preferences. Trends in the market also play a crucial role in the growth of the Medical Technology sector in Southern Asia. One of the key trends is the increasing adoption of digital health technologies. Telemedicine, remote patient monitoring, and health apps are becoming more prevalent, enabling patients to access healthcare services from the comfort of their homes. This trend is particularly relevant in rural areas where access to healthcare facilities may be limited. Additionally, there is a growing emphasis on precision medicine, with healthcare providers leveraging genetic and molecular data to deliver targeted treatments. Local special circumstances further contribute to the development of the Medical Technology market in Southern Asia. Many countries in the region are experiencing a demographic shift, with an aging population and a rising middle class. This demographic change creates a greater demand for healthcare services and technologies. Moreover, the increasing prevalence of chronic diseases, such as diabetes and cardiovascular disorders, necessitates advanced medical technologies for early detection and effective management. Underlying macroeconomic factors also play a significant role in the growth of the Medical Technology market in Southern Asia. Rapid economic growth in countries like India and China has led to increased healthcare spending and greater investment in healthcare infrastructure. Governments in the region are also implementing policies to encourage the adoption of medical technologies and attract foreign investment. These favorable economic conditions create a conducive environment for the expansion of the Medical Technology sector. In conclusion, the Medical Technology market in Southern Asia is experiencing robust growth and development due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The increasing demand for advanced healthcare solutions, the adoption of digital health technologies, the demographic shift, and favorable economic conditions all contribute to the expansion of this sector in the region. As a result, medical technology companies are focusing on developing innovative products and solutions to meet the evolving needs of the Southern Asian market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)